Evogene : First Quarter 2023 Financial Results Release & Conference Call for May 18, 2023

developing and advancing novel microbiome- based therapeutics to treat human disorders powered by MicroBoost AI;


Lavie Bio Ltd. - developing and commercially advancing,... | May 4, 2023

Related Keywords

Israel ,Rehovot ,Hamerkaz ,United States , ,Evogene Ltd ,Nasdaq ,Evogene Schedules First Quarter ,Results Release ,Evogene Ltd Stock Exchange ,News ,Information ,Press Release ,Developing ,End ,Dvancing ,Novel ,Ased ,Herapeutics ,O ,Treat ,Human ,Disorders ,Owered ,Y ,Icroboost ,Davie ,Ohio ,Ommercially Evgn Il0011050551 ,